Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · December 28, 2015

Blood Pressure Control and Risk of Stroke in Atrial Fibrillation

Journal of the American Heart Association

 

Additional Info

Disclosure statements are available on the authors' profiles:

Journal of the American Heart Association
Blood Pressure Control and Risk of Stroke or Systemic Embolism in Patients With Atrial Fibrillation: Results From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial
J Am Heart Assoc 2015 Dec 01;4(12)e002015, MP Rao, S Halvorsen, D Wojdyla, L Thomas, JH Alexander, EM Hylek, M Hanna, MC Bahit, RD Lopes, R De Caterina, C Erol, S Goto, F Lanas, BS Lewis, S Husted, BJ Gersh, L Wallentin, CB Granger,

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading